Vanicoside B

Cat. No.: IBDI-430756

Vanicoside B is a phenylpropanoyl sucrose derivative, can be isolated from the herb Persicaria dissitiflora. Vanicoside B targets cyclin-dependent kinase 8 (CDK8) and exhibits anti-tumor activity. The potential mechanism is Vanicoside B blocks CDK8-mediated signaling pathways and decreases the expression of epithelial-mesenchymal transition proteins, so that it leads to cell cycle arrest and apoptosis.

Product Details

Target	CDK | STAT
Molecular Weight	956.89
SMILES	OC(C=C1)=CC=C1/C=C/C(OC[[email protected]@]2([[email protected]]([[email protected]@H]([[email protected]](O2)COC(/C=C/C3=CC=C(C=C3)O)=O)O)OC(/C=C/C4=CC=C(C=C4)O)=O)O[[email protected]]5O[[email protected]@H]([[email protected]]([[email protected]@H]([[email protected]]5O)O)O)COC(/C=C/C6=CC(OC)=C(C=C6)O)=O)=O
Structure Classification	Phenols>Polyphenols

Storage & Handling

Shipping	Room temperature in continental US. May vary elsewhere.
Storage	Please store the product under the recommended conditions in the Certificate of Analysis.
Regulatory Status	This product is for RESEARCH USE ONLY and is not intended for therapeutic or diagnostic use.